Solutions
Modelling and Simulation
Mechanism of Action Modelling
Exposure Response Modelling
Translational Modelling
Tumour Growth Inhibition Modelling
Population PK and NCA
PBPK Modelling
Clinical Trial Simulation
Biostatistics
Data Science & Bioinformatics
Virtual Tumour
Precision Oncology
Resources
Scientific Content
Investor Content
FAQs
News
All News
Investor News / RNS
Blog
Events
AIM Rule 26
Share Information
Investor News / RNS
Board of Directors
Advisors
Corporate Governance
Financial Reports
Corporate Documents
Registration
About Us
Partners
Team
Careers
Contact
Solutions
Modelling and Simulation
Mechanism of Action Modelling
Exposure Response Modelling
Translational Modelling
Tumour Growth Inhibition Modelling
Population PK and NCA
PBPK Modelling
Clinical Trial Simulation
Biostatistics
Data Science & Bioinformatics
Virtual Tumour
Precision Oncology
Resources
Scientific Content
Investor Content
FAQs
News
All News
Investor News / RNS
Blog
Events
AIM Rule 26
Share Information
Investor News / RNS
Board of Directors
Advisors
Corporate Governance
Financial Reports
Corporate Documents
Registration
About Us
Partners
Team
Careers
Contact
Solutions
Modelling and Simulation
Mechanism of Action Modelling
Exposure Response Modelling
Translational Modelling
Tumour Growth Inhibition Modelling
Population PK and NCA
PBPK Modelling
Clinical Trial Simulation
Biostatistics
Data Science & Bioinformatics
Virtual Tumour
Precision Oncology
Resources
Scientific Content
Investor Content
FAQs
News
All News
Investor News / RNS
Blog
Events
AIM Rule 26
Share Information
Investor News / RNS
Board of Directors
Advisors
Corporate Governance
Financial Reports
Corporate Documents
Registration
About Us
Partners
Team
Careers
Contact
Investor Content
Explore our Investor Content
Our Investor Hub offers easy access to company updates such as latest financial reports, board announcements and investor presentations, to keep you informed of our progress.
1st October 2025 – Investor presentation – Company update
Investor
10th March 2025 – Investor presentation – Company update
Investor
7th October 2024 – Investor presentation – Full Year Results and Company update
Investor
18th March 2024 – Investor presentation – Interim Results and Company update
Investor
29th January 2024 – Investor presentation – Board Changes
Investor
17th November 2023 – Investor presentation – Company update
Investor
6th April 2023 – Investor presentation – Trading and company update
Investor
13th July 2022 – Trading update
Investor
8th March 2022 – Interim results presentation for the six months ended 31 December 2021
Investor
30th September 2021 – Video of full year results presentation 2021
Investor
30th September 2021 – Slide presentation of results for year ended 30 June 2021
Investor
